Barry Investment Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-70,274
| Closed | -$1.24M | – | 77 |
|
|
2017
Q3 | $1.24M | Sell |
70,274
-56,063
| -44% | -$987K | 0.46% | 33 |
|
|
2017
Q2 | $4.2M | Sell |
126,337
-2,345
| -2% | -$77.9K | 1.58% | 22 |
|
|
2017
Q1 | $4.13M | Buy |
128,682
+16,053
| +14% | +$515K | 1.53% | 23 |
|
|
2016
Q4 | $4.08M | Sell |
112,629
-2,458
| -2% | -$89.1K | 1.43% | 24 |
|
|
2016
Q3 | $5.3M | Buy |
115,087
+15,739
| +16% | +$724K | 1.82% | 23 |
|
|
2016
Q2 | $4.99M | Buy |
99,348
+969
| +1% | +$48.7K | 1.94% | 22 |
|
|
2016
Q1 | $5.26M | Buy |
98,379
+2,687
| +3% | +$144K | 1.67% | 23 |
|
|
2015
Q4 | $6.28M | Sell |
95,692
-873
| -0.9% | -$57.3K | 2.04% | 17 |
|
|
2015
Q3 | $5.45M | Buy |
96,565
+1,657
| +2% | +$93.6K | 1.75% | 25 |
|
|
2015
Q2 | $0 | Buy |
94,908
+12,404
| +15% | – | ﹤0.01% | 66 |
|
|
2015
Q1 | $5.14M | Buy |
82,504
+4,504
| +6% | +$281K | 1.57% | 25 |
|
|
2014
Q4 | $4.49M | Buy |
+78,000
| New | +$4.49M | 1.46% | 25 |
|